Unilever eyes GSK's consumer goods arm in possible $68-bn deal
Unilever eyes GSK's consumer goods arm in possible $68-bn deal
Business Standard
Unilever confirms interest in GSK assets, says GSK consumer business would be 'strong strategic fit'; UK's Sunday Times says 50 billion-pound bid rejected in late 2021
Business Line
Is the first monoclonal antibody to report preclinical data demonstrating activity against all tested SARS-CoV-2 variants of concern
New data shows GSK-Vir drug works against all Omicron mutations
New data shows GSK-Vir drug works against all Omicron mutations
Economic Times
The data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, GSK said in a statement.
default
Covid: GSK says tests show antibody drug works against Omicron variant
Covid: GSK says tests show antibody drug works against Omicron variant
Business Standard
Sotrovimab, developed with Vir, tested in lab, on hamsters; key mutations of Omicron did not elude drug activity in study
At $54-bn value, interest in GSK's arm may lead to biggest-ever buyout
At $54-bn value, interest in GSK's arm may lead to biggest-ever buyout
Business Standard
Advent International, CVC Capital Partners and KKR are among potential suitors for GSK's consumer unit
Business Line
Fighting against malariaThe WHO's approval of anti-malarial vaccine Mosquirix' developed by British drug maker GSK has marked a momentous development
WHO recommends world's first malaria vaccine for children at risk
WHO recommends world's first malaria vaccine for children at risk
Economic Times
The decision followed a review of a pilot programme deployed since 2019 in Ghana, Kenya and Malawi in which more than two million doses were given of the vaccine, first made by the pharmaceutical company GSK in 1987.
default
GSK Consumer Healthcare expands Sensodyne portfolio in India
GSK Consumer Healthcare expands Sensodyne portfolio in India
livemint
The Sensodyne Sensitivity & Gum portfolio will be available pan India across groceries, pharmacies, retail chains and e-commerce players
GlaxoSmithKline Consumer Healthcare Ltd.    
22 Aug 2021, 10:59PM
GSK bets on specialty drugs, jabs for growth after drab Q1
GSK bets on specialty drugs, jabs for growth after drab Q1
livemint
GSK's growth in revenues was led by dermatology, anti-infectives and analgesics but beyond this, sales were low
GSK, CureVac's next-gen Covid vaccine shows promise in monkey trial
GSK, CureVac's next-gen Covid vaccine shows promise in monkey trial
Business Standard
The encouraging news on its "second-generation" vaccine gave CureVac's German-listed shares an 8% lift, as the stock gradually recovers from a slump in June
45 Votes:
Buy77.78%
Sell11.11%
Hold11.11%
BUY
SELL
HOLD